Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: OPCH (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
10 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Year Target Price $38.56
Year Target Price $38.56
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.13% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.28B USD | Price to earnings Ratio 25.8 | 1Y Target Price 38.56 |
Price to earnings Ratio 25.8 | 1Y Target Price 38.56 | ||
Volume (30-day avg) - | Beta 0.75 | 52 Weeks Range 21.39 - 35.53 | Updated Date 06/29/2025 |
52 Weeks Range 21.39 - 35.53 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.25 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.12% | Operating Margin (TTM) 5.94% |
Management Effectiveness
Return on Assets (TTM) 6.33% | Return on Equity (TTM) 15.38% |
Valuation
Trailing PE 25.8 | Forward PE 21.6 | Enterprise Value 6332436812 | Price to Sales(TTM) 1.02 |
Enterprise Value 6332436812 | Price to Sales(TTM) 1.02 | ||
Enterprise Value to Revenue 1.22 | Enterprise Value to EBITDA 15.68 | Shares Outstanding 163747008 | Shares Floating 154380907 |
Shares Outstanding 163747008 | Shares Floating 154380907 | ||
Percent Insiders 0.69 | Percent Institutions 103.96 |
Analyst Ratings
Rating 4.5 | Target Price 38.56 | Buy 3 | Strong Buy 6 |
Buy 3 | Strong Buy 6 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health, Inc. (OCRX) was founded in 1996 (as Walgreen Infusion Services), becoming a publicly traded company in 2019 after a merger. It has grown through acquisitions and organic expansion, focusing on providing home and alternate site infusion services.
Core Business Areas
- Infusion Therapy Services: Provides intravenous therapies for various acute and chronic conditions, including anti-infectives, nutrition support, and immune globulin therapy.
- Specialty Pharmacy Services: Offers access to specialty medications and support services for patients with complex conditions.
- Disease Management Programs: Develops programs to manage chronic diseases and improve patient outcomes.
Leadership and Structure
John C. Rademacher is the CEO. The company has a board of directors and operates with regional and functional leadership teams to manage its nationwide operations.
Top Products and Market Share
Key Offerings
- Anti-Infective Infusion: Intravenous antibiotics and antifungals for treating infections at home or in alternate care settings. Competitors include CVS Health (CVS) and OptumRx. Market share data is not publicly broken down by specific therapy but as a whole the companies are competing for 20-30 Billion TAM.
- Revenue:
- Nutrition Support (TPN): Total parenteral nutrition for patients unable to receive adequate nutrition through oral or enteral routes. Competitors include CVS Health (CVS) and OptumRx. Market share data is not publicly broken down by specific therapy but as a whole the companies are competing for 20-30 Billion TAM.
- Revenue:
- Immune Globulin Infusion (IVIG): Intravenous immunoglobulin therapy for treating immune deficiencies and autoimmune disorders. Competitors include CVS Health (CVS) and OptumRx. Market share data is not publicly broken down by specific therapy but as a whole the companies are competing for 20-30 Billion TAM.
- Revenue:
Market Dynamics
Industry Overview
The infusion therapy market is growing due to an aging population, increasing prevalence of chronic diseases, and a shift towards home-based care. Technological advancements and cost-effectiveness drive demand.
Positioning
Option Care Health is a leading independent provider of home and alternate site infusion services, differentiating itself through clinical expertise, comprehensive service offerings, and a strong focus on patient care.
Total Addressable Market (TAM)
The total addressable market is estimated at $20-30 billion, with Option Care Health well-positioned to capture a significant share due to its nationwide network and established relationships with payers and providers.
Upturn SWOT Analysis
Strengths
- Nationwide network of infusion centers and pharmacies
- Strong relationships with payers and providers
- Clinical expertise and comprehensive service offerings
- Focus on patient care and outcomes
Weaknesses
- Reliance on reimbursement rates from payers
- Exposure to regulatory changes in the healthcare industry
- Competition from larger players like CVS and OptumRx
- Potential for supply chain disruptions
Opportunities
- Expanding into new geographic markets
- Developing new disease management programs
- Acquiring smaller infusion therapy providers
- Leveraging technology to improve patient care and efficiency
Threats
- Changes in reimbursement policies
- Increased competition from other infusion therapy providers
- Drug shortages and supply chain disruptions
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- CVS (CVS)
- UnitedHealth Group (UNH) - OptumRx
Competitive Landscape
Option Care Health competes with larger companies like CVS and OptumRx, but differentiates itself through its focus on infusion therapy and personalized patient care.
Major Acquisitions
BioMatrix Holdings
- Year: 2021
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded Option Care Health's geographic reach and specialty pharmacy capabilities.
Growth Trajectory and Initiatives
Historical Growth: Option Care Health has grown through acquisitions and organic expansion.
Future Projections: Analyst estimates vary, but generally project continued revenue and earnings growth. Please check with current analysts reports.
Recent Initiatives: Expansion of service offerings, investment in technology, and strategic acquisitions.
Summary
Option Care Health is a strong player in the growing infusion therapy market, benefiting from its nationwide network and clinical expertise. While facing competition from larger companies and regulatory pressures, it has opportunities to expand its service offerings and geographic reach. The absence of dividends may deter some investors, but its growth potential makes it an attractive investment.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings, Investor presentations, Industry reports, Analysts reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share data is estimated based on available information and may not be exact. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://www.optioncarehealth.com |
Full time employees 8000 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.